Cancer biomarkers
Cancer Biomarkers publishes research on molecular markers for cancer detection, prognosis and treatment response, read by laboratory medicine and translational oncology researchers.
Overview
Cancer Biomarkers, subtitled section A of Disease Markers, has been published since 2005 and moved to SAGE Publications in Thousand Oaks, California, in 2024 after IOS Press, its founding publisher, became part of SAGE; Crossref lists SAGE Publications as the publisher. As its title indicates, its subject is biomarkers of cancer, the molecular and cellular markers used in cancer diagnosis, prognosis and treatment monitoring. The NLM record lists it as a United States serial that is indexed in MEDLINE; it is not listed in DOAJ.
Pages like this
not linked directly; found by shared links- JournalThe International journal of biological markers
Shares Biomarker, PubMed & Europe PMC.
- JournalTumour biology
Shares Biomarker, PubMed & Europe PMC.